Our integrated approach is speeding the development of new and better immunotherapies for patients with solid tumor cancers, blood cancers and other non-cancerous disorders.
Fred Hutch's award-winning Cancer Surveillance System database, part of the national Surveillance, Epidemiology and End Results Program, has received a contract renewal of up to 10 years from the NCI.
The American Society of Clinical Oncology meeting is June 1-5 in Chicago. This year’s theme is “Delivering Discoveries: Expanding the Research of Precision Medicine." Learn more about the Hutch presence.